Omicron: a drug developer’s perspective

Fang Flora Fang, Pei Yong Shi

Research output: Contribution to journalComment/debatepeer-review


We performed an annotation of 35 mutations in the spike protein of the SARS-CoV-2 Omicron variant. Our analysis of the mutations indicates that Omicron has gained prominent immune evasion and potential for enhanced transmissibility. Previous modeling study has revealed that continued evolution in both immune evasion and enhanced transmissibility by SARS-CoV-2 would compromise vaccines as tools for the pandemic control. To combat the future variants of SARS-CoV-2, the world needs novel antiviral drugs that are effective at curb viral spreading without introducing additional selective pressure towards resistant variants.

Original languageEnglish (US)
Pages (from-to)208-211
Number of pages4
JournalEmerging Microbes and Infections
Issue number1
StatePublished - 2022


  • COVID19
  • COVID19drugs
  • COVID19vaccines
  • Omicron variants
  • SARS-CoV-2

ASJC Scopus subject areas

  • Drug Discovery
  • Infectious Diseases
  • Epidemiology
  • Virology
  • Parasitology
  • Microbiology
  • Immunology


Dive into the research topics of 'Omicron: a drug developer’s perspective'. Together they form a unique fingerprint.

Cite this